Related Experiment Video
Updated: Sep 11, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Multiple drug resistance in Candida albicans
R Prasad1, S K Murthy, V Gupta
1School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Abstract:
By functional complementation of a PDR 5 (pleiotropic drug resistance) null mutant of S. cerevisiae, we have recently cloned and sequenced a multidrug resistance gene CDR 1 (Candida Drug Resistance). Transformation by CDR 1 of a PDR 5 disrupted host hypersensitive to cycloheximide and chloramphenicol resulted in resistance to these as well as other unrelated drugs. The nucleotide sequence of CDR 1 revealed that, like PDR 5, it encodes a putative membrane pump belonging to the ABC superfamily. CDR 1 encodes a protein of 169.9 kDa whose predicted structural organisation is characterised by two homologous halves, each comprising a hydrophobic region, with a set of six transmembrane stretches, preceded by a hydrophilic binding fold. We now have evidence to suggest that there are several PDR homologues present in C. albicans which display multidrug resistance and a collateral sensitivity pattern different from PDR 5 and CDR 1. The functions of such genes and their products in the overall physiology of C. albicans is not yet established.
Insights
Researchers identified the Candida Drug Resistance (CDR 1) gene, which confers multidrug resistance by encoding an ABC superfamily membrane pump. This finding advances understanding of drug resistance mechanisms in fungi.
Area of Science:
- Molecular Biology
- Mycology
- Biochemistry
Background:
- Pleiotropic drug resistance (PDR) genes are crucial for fungal survival against toxic compounds.
- Understanding multidrug resistance mechanisms in pathogenic fungi like Candida albicans is vital for effective treatment.
Purpose of the Study:
- To clone and characterize a novel multidrug resistance gene from Candida albicans.
- To investigate the functional role of the identified gene in conferring resistance to various drugs.
Main Methods:
- Functional complementation of a Saccharomyces cerevisiae PDR5 null mutant.
- Gene sequencing and nucleotide analysis.
- Protein structure prediction using bioinformatics tools.
Main Results:
- Cloning and sequencing of the Candida Drug Resistance (CDR 1) gene.
- CDR 1 confers resistance to cycloheximide, chloramphenicol, and other unrelated drugs when expressed in a sensitive host.
- CDR 1 encodes a putative ABC superfamily transporter with a characteristic bipartite structure.
Conclusions:
- CDR 1 is a functional multidrug resistance gene in Candida species.
- The identified transporter shares structural similarities with known PDR proteins.
- Evidence suggests the presence of multiple PDR homologues in Candida albicans with distinct resistance profiles.
Related Concept Videos
Treatment Resistant Cancers
Development of Antibiotic Resistance
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

